26 related articles for article (PubMed ID: 9830317)
1. Lp(a) is increased in hemodialysis patients according to the type of dialysis membrane: a 2-year follow-up study.
Diop ME; Viron B; Bailleul S; Lefevre G; Fessi H; Maury J; Etienne J; Couderc R
Clin Nephrol; 2000 Sep; 54(3):210-7. PubMed ID: 11020019
[TBL] [Abstract][Full Text] [Related]
2. [Serum lipids in diminished kidney function, during hemodialysis and after kidney transplantation].
Frey FJ; Mordasini RC; Schlumpf E; Marone C; Montandon A; Flury W; Riva G
Schweiz Med Wochenschr; 1977 Sep; 107(36):1248-53. PubMed ID: 199937
[TBL] [Abstract][Full Text] [Related]
3. Dyslipidemia in patients with chronic renal failure and in renal transplant patients.
Shah B; Nair S; Sirsat RA; Ashavaid TF; Nair KG
J Postgrad Med; 1994; 40(2):57-60. PubMed ID: 8737552
[TBL] [Abstract][Full Text] [Related]
4. Lipoprotein (a) in patients on hemodialysis.
Díaz-Peromingo JA; Carbajal DG; Albán-Salgado A
Acta Med Austriaca; 2004 Aug; 31(3):73-5. PubMed ID: 15515480
[TBL] [Abstract][Full Text] [Related]
5. Incidence of gallstones in chronic renal failure patients undergoing hemodialysis: experience of a center in Turkey.
Altiparmak MR; Pamuk ON; Pamuk GE; Celik AF; Apaydin S; Cebi D; Mihmanli I; Erek E
Am J Gastroenterol; 2003 Apr; 98(4):813-20. PubMed ID: 12738461
[TBL] [Abstract][Full Text] [Related]
6. [Lipoprotein(a) and lipids in chronic renal insufficiency and kidney transplant].
Ochoa-Sosa CA; Mondragón-Rodríguez G; Zamora-González J; Cardoso-Saldaña G; Herrera-Acosta J; Posadas-Romero C
Rev Invest Clin; 1998; 50(4):301-6. PubMed ID: 9830317
[TBL] [Abstract][Full Text] [Related]
7. [Kidneys and lipids].
Bagros P; Aparicio M
Rev Prat; 1992 Feb; 42(4):417-20. PubMed ID: 1604159
[TBL] [Abstract][Full Text] [Related]
8. [Lipoprotein disorders in chronic kidney failure, nephrotic syndrome and dialysis].
Kes P; Reiner Z; Brunetta B
Lijec Vjesn; 2002; 124(11-12):372-7. PubMed ID: 12679979
[TBL] [Abstract][Full Text] [Related]
9. Lipid changes and statins in chronic renal insufficiency and dialysis.
Wanner C; Krane V; Metzger T; Quaschning T
J Nephrol; 2001; 14 Suppl 4():S76-80. PubMed ID: 11798151
[TBL] [Abstract][Full Text] [Related]
10. Lipoprotein(a) levels in patients receiving renal replacement therapy: methodologic issues and clinical implications.
Levine DM; Gordon BR
Am J Kidney Dis; 1995 Jul; 26(1):162-9. PubMed ID: 7611248
[TBL] [Abstract][Full Text] [Related]
11. Lipid abnormalities in end stage renal disease.
Oda H; Keane WF
Nephrol Dial Transplant; 1998; 13 Suppl 1():45-9. PubMed ID: 9507498
[No Abstract] [Full Text] [Related]
12. Low molecular weight heparin--does it favourably affect lipid levels?
Stenvinkel P
Nephrol Dial Transplant; 1995; 10(1):16-8. PubMed ID: 7724021
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
